BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10413362)

  • 21. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells.
    Anderson GW; Rowland RR; Palmer GA; Even C; Plagemann PG
    J Virol; 1995 Aug; 69(8):5177-85. PubMed ID: 7609091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
    McDonald TL; Donnelly T; Weber A; Quenette L
    Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential anti-Golgi complex autoantibody production following murine lactate dehydrogenase-elevating virus infection.
    Nozawa K; Fritzler MJ; Ikeda K; Takasaki Y; Satoh M; Chan EK
    Immunopharmacol Immunotoxicol; 2008; 30(1):13-25. PubMed ID: 18306101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
    Broen JB; Bradley DS; Powell KM; Cafruny WA
    Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Rowland RR; Butz EA; Plagemann PG
    J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
    Morimoto M; Ohji T; Iwata H; Hayashi T
    Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
    Weiland E; Weiland F; Grossmann A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.
    McDonald TL
    Immunology; 1982 Feb; 45(2):365-70. PubMed ID: 6977483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
    van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
    J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
    Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
    Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.
    Chen Z; Rowland RR; Anderson GW; Palmer GA; Plagemann PG
    J Virol; 1997 Apr; 71(4):2913-20. PubMed ID: 9060649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.
    Plagemann PG; Chen Z; Li K
    Arch Virol; 2001 Jul; 146(7):1283-96. PubMed ID: 11556706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactic dehydrogenase virus inhibits allergic immunoglobulin E production: in vivo molecular analysis of cytokines.
    Morimoto M; Iwata H; Hayashi T
    Scand J Immunol; 1999 Aug; 50(2):211-4. PubMed ID: 10447927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons.
    Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():581-92. PubMed ID: 7897349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.
    Plagemann PG
    Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
    Gómez KA; Coutelier JP; Retegui LA
    Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus.
    Cafruny WA; Plagemann PG
    Infect Immun; 1982 Sep; 37(3):1007-12. PubMed ID: 7129627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection.
    Broen JJ; Cafruny WA
    Reg Immunol; 1993; 5(1):44-52. PubMed ID: 8347469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.